Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

UPDATE 2-S.Korea warns against lax distancing as daily COVID-19 count hits one-month high

Published 17/02/2021, 06:35 pm

(Adds Astrazeneca final approval, planned vaccination drill, syringe deals; paragraphs 6-9)

By Hyonhee Shin

SEOUL, Feb 17 (Reuters) - South Korea's Prime Minister Chung Sye-kyun on Wednesday warned against loosening enforcement of social distancing rules after the number of new coronavirus cases hit the highest levels in nearly 40 days.

The government relaxed distancing curbs starting this week, after getting on top of a third wave of COVID-19 outbreaks that peaked at about 1,200 daily cases in late December.

But the numbers shot back up in just three days, topping 600 for the first time in 39 days on Tuesday, after a ban on nighttime entertainment facilities was lifted and a restaurant curfew extended by one hour to 10 p.m.

Chung said there were signs of lax discipline, singling out nightclubs opening at 5 a.m. and people partying at a hotel after the curfew.

"We've eased distancing to help small business owners maintain their livelihoods, not to keep a slack rein on the virus," he told a televised meeting. "The third wave is not over ... now is never the time to loosen up."

South Korea's drug safety ministry granted final approval on Wednesday for a shipment of 1.57 million doses of AstraZeneca (NASDAQ:AZN)'s AZN.L coronavirus vaccine, as authorities gear up to begin vaccinating healthcare workers on Feb. 26.

The doses will be produced by local drugmaker SK bioscience, which is scheduled to deliver its first batch on Feb. 24.

Authorities plan to hold a vaccination drill on Friday under real-life scenarios for shipping the Astrazeneca products to a local clinic where inoculation will take place.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The government has secured deals to procure 40 million special syringes from two local manufacturers that could improve the efficiency of the vaccines by 20% by minimising drug residues left in needles, a health official told Reuters.

The Korea Disease Control and Prevention Agency (KDCA) reported 621 cases as of Tuesday midnight, from in the 300-400s in the previous few days as testing increased after last week's Lunar New Year holidays.

Authorities are on high alert as more cluster infections could emerge because of the holidays, during which millions of Koreans travelled across the country to visit relatives or tourist sites.

If the numbers continue to surge, the government will consider reinstating stricter curbs to prevent a fourth wave before its vaccination campaign begins on Feb. 26, said Son Young-rae, a senior health ministry official.

"March and April are when another wave is most likely to occur because vaccination could bring weaker vigilance in general and public fatigue toward distancing is rising," Son told reporters.

South Korea's total infections grew to 84,946 cases, with 1,538 deaths. (Editing by Gerry Doyle)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.